Skip to main content
logo
Argenica Therapeutics Limited (ASX:AGN)
Australia flag Australia · Delayed Price · Currency is AUD
0.1900
-0.0050 (-2.56%)
Aug 26, 2026, 4:10 PM AEST

Argenica Therapeutics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-1.37-7.17-5.48-4.82-4.09
Stock-Based Compensation
0.030.110.140.460.43
Change in Accounts Receivable
0.35-0.03-0.23-0.07-0
Change in Accounts Payable
-2.611.470.450.460.29
Change in Unearned Revenue
-0.62-0.090.050.66-
Change in Other Net Operating Assets
0.020.010.020.010.02
Operating Cash Flow
-4.19-5.7-5.06-3.3-3.36
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Investment in Securities
--0.05-0.05-
Investing Cash Flow
--0.05-0.05-

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Issuance of Common Stock
-0.3511.633.735.13
Other Financing Activities
-0--00
Financing Cash Flow
-00.3511.633.735.13

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash Flow
-4.19-5.366.620.371.77

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Levered Free Cash Flow
-3.68-3.34-3.11-1.52-1.82
Unlevered Free Cash Flow
-3.68-3.34-3.11-1.52-1.82

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Interest Paid
-0000
Cash Income Tax Paid
--2.76-2.09-1.38-0.26
Change in Working Capital
-2.861.360.281.050.3